Search results for "molecular microbiology"

Enzyme Immunoassay for the quantitative determination of Nilotinib in serum, plasma and cell culture supernatant

Discover the game-changing advancements and key discussions driving lab automation forward

Catch up on the latest lab automation hot topics and new technology from SLAS2023

From tackling post-pandemic changes in the biopharmaceutical supply chain to addressing unmet therapeutic needs, simplified off-target effect analysis, and more, explore the latest advances in drug discovery with these free resources

The Jackson Laboratory explores the efficacy of humanized mice as an alternative to non-human primates in drug development studies

The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly

How advanced imaging technology is progressing drug discovery through understanding of GPCR-dependent second-messenger systems

On World AIDS Day, SelectScience looks at advances in HIV diagnostic testing and monitoring

As concerns about PFAS health risks rise, advancements in chromatography are transforming our understanding of these persistent chemicals. Explore how innovative techniques enhance detection and analysis, paving the way for safer environments and better public health.

Novel cyclic IMS and new SYNAPT XS lead Waters’ portfolio of solutions that promise unlimited experimental opportunities and analytical flexibility

Learn how AstraZeneca is adopting nascent cryo-electron microscopy (cryo-EM) technology to expand its targets for drug discovery

Agreement adds commercial firepower for QIAGEN’s U.S. launch of the next-generation platform for syndromic insights initially for respiratory conditions

A new network in the US – the Readiness Acceleration and Innovation Network, or RAIN for short – is catalyzing biotech business and training the next generation of young scientists to work in a laboratory setting. As ever, equipment is key

In this editorial feature, we bring you the latest developments in gene editing and CRISPR technology

Dr. Megan Allyse from the Mayo Clinic Center for Individualized Medicine explains why gene editing is not yet suitable for medical practice

QIAGEN’s GeneReader NGS System Gains Further Validation in Oncology Research Applications with New Independent Performance Review Data

Kerafast's innovative scheme offers access to hundreds of reagents

Hear how David Foley, Principal Scientist at Pfizer, uses reaction monitoring NMR spectroscopy